The Founder's Guide to

AMR Action Fund

Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.

Explore our founder-friendly guide and choose if you'd like to be connected.
We'll either provide a warm intro or provide you with more suitable alternatives.
Once you're put in touch, we'll provide you with helpful advice. It's 100% free.

Overview

The AMR Action Fund is a venture capital fund formed through collaborations with the International Federation of Pharmaceutical Manufacturers and Associations, the World Health Organization, the European Investment Bank, and the Wellcome Trust. Based globally, the fund focuses on addressing antimicrobial resistance (AMR) by investing in innovative therapeutic solutions. It currently supports 11 portfolio companies and aims to launch two to four new antimicrobials by 2030.

Learn More

Frequently Asked Questions

Does AMR Action Fund lead rounds?

Yes, the AMR Action Fund often leads investment rounds in its portfolio companies, particularly in the pre-seed and seed stages.

What is AMR Action Fund's stance on follow-on investments?

The fund is open to follow-on investments, especially for companies that demonstrate significant progress in their development of antimicrobial therapies.

How large is AMR Action Fund's current fund?

The specific size of the current fund is not publicly disclosed, but it is focused on supporting multiple clinical-stage companies in the biotech sector.

All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.